FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 292:278-281 February 6, 1975 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Since it is still uncertain whether moderate degrees of alpha1-antitrypsin deficiency predispose to the development of lung disease, data obtained from a stratified random sample of white households in Tucson, Arizona, consisting of 2586 subjects over five years of age, were analyzed. No relation was found between serum alpha1-antitrypsin levels, measured as trypsin inhibitory capacity, and ventilatory function, respiratory symptomatology, or frequency of diagnosed pulmonary diseases even among cigarette smokers. The data indicate that an intermediate level of alpha1-antitrypsin deficiency (i.e., inhibitory capacity between 20 and 62 per cent of the population's mean value) is not an important risk factor for the development of chronic obstructive lung diseases. The data militate strongly against the use of any quantitative determination of alpha1-antitrypsin as a test to identify subjects with moderate deficiency for the purpose of predicting later development of chronic respiratory disorders. The rate of severe deficiency is so low as to make population screening for such subjects impractical.

This article has been cited by other articles:

• Silva, G. E., Guerra, S., Keim, S., Barbee, R. A., Sherrill, D. L. (2008). Longitudinal Decline of Diffusing Capacity of the Lung for Carbon Monoxide in Community Subjects With the PiMZ {alpha}1-Antitrypsin Phenotype. Chest 133: 1095-1100 [Abstract] [Full Text]  
• Dahl, M., Hersh, C. P., Ly, N. P., Berkey, C. S., Silverman, E. K., Nordestgaard, B. G. (2005). The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 26: 67-76 [Abstract] [Full Text]  
• (2003). American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am. J. Respir. Crit. Care Med. 168: 818-900 [Full Text]  
• Silva, G. E., Sherrill, D. L., Guerra, S., Barbee, R. A. (2003). A Longitudinal Study of {alpha}1-Antitrypsin Phenotypes and Decline in FEV1 in a Community Population. Chest 123: 1435-1440 [Abstract] [Full Text]